Food Science and Biotechnology

, Volume 22, Issue 6, pp 1699–1705 | Cite as

In vitro cytoprotective effect of infant milk formula fortified with human rotavirus-specific hyperimmune yolk immunoglobulins (IgY)

  • Shofiqur RahmanEmail author
  • Kouji Umeda
  • Faustino C. IcatloJr.
  • Ki Woong Lee
  • Sung Han Kim
  • Hyuk Joon Choi
  • Bok-Kyung Han
  • Young-Seo Park
  • Nguyen Van Sa
Research Article


Infant formula supplemented with hyperimmune immunoglobulin Y (IgY) against human rotavirus (HRV) was evaluated in vitro against HRV reassortant clinical strains ATCC VR 2273 and ATCC VR 2274. Specific antihuman rotavirus antibody powder (Rotamix IgY) was prepared. The effectiveness of Rotamix IgY alone and as a pre-mixed solution with infant formula was evaluated for neutralizing rotavirus infectivity in MA104 cells. The test infant formula cross-reacted strongly against different human rotavirus strains with titers of 80-320 using a 50% fluorescent focus (FF) inhibition test. Both rotamix IgY alone and in a pre-mixed solution with infant formula showed multi-serotypic cross neutralization activities against the major rotavirus global serotypes G1, G2, G3, and G4 alone and with other human and animal-strains in vitro. Cell-rotavirus adhesion and cell damage arising from rotavirus infection were significantly inhibited in a dose dependent manner, compared to control IgY supplemented infant formula.


rotavirus immunoglobulin Y infant formula 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cortese MM, Parashar UD. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm. Rep. 58: 1–25 (2009)Google Scholar
  2. 2.
    Dennehy P. Rotavirus vaccines: An overview. Clin. Microbiol. Rev. 21: 198–208 (2008)CrossRefGoogle Scholar
  3. 3.
    Ramachandran M, Das BK, Vij A, Kumar R, Bhambal SS, Kesari N, Rawat H, Bahl L, Thakur S, Woods PA, Glass RI, Bhan MK, Gentsch JR. Unusual diversity of human rotavirus G and P genotypes in India. J. Clin. Microbiol. 34: 436–439 (1996)Google Scholar
  4. 4.
    Yolken RH, Peterson JA, Vonderfecht SL, Fouts ET, Midthun K, Newburg DS. Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis. J. Clin. Invest. 90: 1984–1991 (1992)CrossRefGoogle Scholar
  5. 5.
    Sarker SA, Pant N, Juneja LR, Hammarstrom L. Successful treatment of rotavirus-induced diarrhoea in suckling mice with egg yolk immunoglobulin. J. Health Popul. Nutr. 4: 465–468 (2007)Google Scholar
  6. 6.
    Ibrahimel SM, Rahman AK, Isoda R, Umeda K, Van Sa N, Kodama Y. In-vitro and in-vivo effectiveness of egg yolk antibody against Candida albicans (anti-CA IgY). Vaccine 26: 2073–2080 (2008)Google Scholar
  7. 7.
    Nguyen SV, Icatlo FC Jr, Nakano T, Isogai E, Hirose K, Mizugai H, Kobayashi-Sakamoto M, Isogai H, Chiba I. Anti-cell-associated glucosyltransferase immunoglobulin Y suppression of salivary mutans streptococci in healthy young adults. J. Am. Dent. Assoc. 142: 943–949 (2011)Google Scholar
  8. 8.
    Sa NV, Umeda K, Yokoyama H, Tohya Y, Kodama Y. Passive protection of dogs against clinical disease due to canine parvovirus-2 by specinfant formulaic antibody from chicken egg yolk. Can. J. Vet. Res. 70: 62–64 (2006)Google Scholar
  9. 9.
    Carlander D, Kollberg H, Wejaker PE, Larsson A. Peroral immunotherapy with yolk antibodies for the prevention and treatment of enteric infections. Immunol. Res. 21: 1–6 (2000)CrossRefGoogle Scholar
  10. 10.
    Ikemori Y, Kuroki M, Peralta RC, Yokoyama H, Kodama Y. Protection of neonatal calves against fatal enteric colibacillosis by administration of egg yolk powder from hens immunized with K99-piliated enterotoxigenic Escherichia coli. Am. J. Vet. Res. 53: 2005–2008 (1992)Google Scholar
  11. 11.
    Kuroki M, Ohta MY, Ikemori Y, Icatlo Jr FC, Kobayashi C, Yokoyama H, Kodama Y. Field evaluation of chicken egg yolk immunoglobulins specinfant formulaic for bovine rotavirus in neonatal calves. Arch. Virol. 142: 843–851 (1997)CrossRefGoogle Scholar
  12. 12.
    Yokoyama H, Hashi T, Umeda K, Icatlo FC Jr, Kuroki M, Ikemori Y, Kodama Y. Effect of oral egg antibody in experimental F18+ Escherichia coli infection in weaned pigs. J. Vet. Med. Sci. 59: 917–921 (1997)CrossRefGoogle Scholar
  13. 13.
    Hiraga C, Kodama Y, Sugiyama T, Ichikawa Y. Prevention of human rotavirus infection with chicken egg yolk immunoglobulins containing rotavirus antibody in cat. Kansenshogaku Zasshi 64: 118–123 (1990)Google Scholar
  14. 14.
    Rahman S, Higo-Moriguchi K, Htun KW, Taniguchi K, Icatlo FC Jr, Tsuji T, Kodama Y, Van Nguyen S, Umeda K, Oo HN, Myint YY, Htut T, Myint SS, Thura K, Thu HM, Fatmawati NN, Oguma K. Randomized placebo-controlled clinical trial of immunoglobulin Y as adjunct to standard supportive therapy for rotavirus-associated diarrhea among pediatric patients. Vaccine 30: 4661–4669 (2012)CrossRefGoogle Scholar
  15. 15.
    Ward RL. Human rotaviruses, vaccines and method. U.S. Patent 5,474,773 (1995)Google Scholar
  16. 16.
    Rahman AKMS, Ibrahim ESM, Isoda R, Umeda K, Nguyen VS, Kodama Y. Effect of passive immunization by anti-gingipain IgY on periodontal health of dogs. Vet. Sci. Dev. 1e-8: 35–39 (2011)Google Scholar
  17. 17.
    Moriguchi KH, Akahori Y, Iba Y, Kurosawa Y, Taniguchi K. Isolation of human monoclonal antibodies that neutralize human rotavirus. J. Virol. 78: 3325–3332 (2004)CrossRefGoogle Scholar
  18. 18.
    Taniguchi K, Urasawa S, Urasawa T. Preparation and characterization of neutralizing monoclonal antibodies with different reactivity patterns to human rotaviruses. J. Gen. Virol. 6: 1045–1053 (1985)CrossRefGoogle Scholar
  19. 19.
    Santos N, Hoshino Y. Global distribution of rotavirus serotypes/ genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev. Med. Virol. 15: 29–56 (2005)CrossRefGoogle Scholar
  20. 20.
    Moe K, Thu HM, Oo WM, Ave KM, Shwe TT, Mar W, Kirkwood CD. Genotyping of rotavirus isolates collected from children less than 5 years of age admitted for diarrhea at the Yangon Children’s Hospital, Myanmar. Vaccine 27(Suppl. 5): F89–F92 (2009)CrossRefGoogle Scholar
  21. 21.
    Widdowson MA, Steele D, Vojdani J, Wecker J, Parashar U. Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines. J. Infect. Dis. 200 (Suppl. 1): S1–S8 (2009)CrossRefGoogle Scholar
  22. 22.
    Meiji SA, Tin SA, Khin YO, Ne W, Ghosh S, Yamamoto D, Kobayashi N. Phylogenetic analysis of human rotavirus in Myanmar: Detection of Indian-Bangladesh G1/G2 lineages, Chinese G3 lineages and OP354-like P[8] lineage (P[8]b subtype). Se. Asian J. Trop. Med. 41: 1393–1404 (2010)Google Scholar
  23. 23.
    Matthijnssens J, Ciarlet M, McDonald SM, Attoui H, Bányai K, Brister JR. Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch. Virol. 156: 1397–1413 (2011)CrossRefGoogle Scholar
  24. 24.
    Ward RL, Nakagomi O, Knowlton DR, McNeal MM, Nakagomi T, Clemens JD, Sack DA, Schiff GM. Evidence for natural reassortants of human rotaviruses belonging to different genogroups. J. Virol. 64: 3219–25 (1990)Google Scholar
  25. 25.
    Nilsson E, Kollberg H, Johannesson M, Wejåker PE, Carlander D, Larsson A. More than 10 years’ continuous oral treatment with specinfant formulaic immunoglobulin Y for the prevention of Pseudomonas aeruginosa infections: A case report. J. Med. Food 10: 375–378 (2007)CrossRefGoogle Scholar

Copyright information

© The Korean Society of Food Science and Technology and Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Shofiqur Rahman
    • 1
    Email author
  • Kouji Umeda
    • 1
  • Faustino C. IcatloJr.
    • 1
  • Ki Woong Lee
    • 2
  • Sung Han Kim
    • 2
  • Hyuk Joon Choi
    • 3
  • Bok-Kyung Han
    • 3
  • Young-Seo Park
    • 4
  • Nguyen Van Sa
    • 1
  1. 1.Immunology Research Institute in GifuEW Nutrition Japan K.K.GifuJapan
  2. 2.Namyang DairySejongKorea
  3. 3.BK bio Co., Ltd.SeongnamKorea
  4. 4.Department of Food Science and BiotechnologyGachon UniversitySeongnamKorea

Personalised recommendations